Thermo Fisher Scientific Inc company logo

# 1st Gen Model Thermo Fisher Scientific Inc Measuring & controlling devices, not elsewhere classified

  • $175.47Last close price
    at 22-jun-2017
  • Subscribe >> Deal exit on
    June 23, 2017
    Deal entry on
    June 23, 2017
  • 0.31%Expected margin
  • 60.00% successful of 50 deals


Model's trade recommendations 1.10% Return for period

0.49% Annual return

$68.70B Market Cap

β 1.05  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 1.10%
52wk return -3.45%
52wk Range
Sortino ratio 0.09
Sharpe ratio 0.06
Norm. RMSE 0.15%
Downside risk 7.07%
Volatility 9.77%
  • 0.60 (0.34%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.

Industry sector: Medical

Sector classification: Measuring & controlling devices, not elsewhere classified

Deep Learning based analysis and prediction model for Thermo Fisher Scientific Inc (TMO) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for TMO model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 389M
P/E 20.54
Shares Outstanding 391M
% Held by Insiders 0.49%
% Held by Institutions 86.94%
EPS (last reported FY) $8.27
EPS (last reported Q) $2.08
EPS, estimated (last reported Q) $2.02
Total revenues $18 B
Net income $2 B